Yokosuka, Japan

Hiroshi Nishida

This inventor holds 2 USPTO granted patents. Top assignee: Mercian Corporation. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Nishida. Retrieved from https://idiyas.com/inventor/hiroshi-nishida-hrxqkos9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroshi Nishida: Innovator in Antibiotic Development

Introduction

Hiroshi Nishida is a prominent inventor based in Yokosuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Nishida's latest patents include the antibiotics Mer-AF1032A and Mer-AF1032B. Antibiotic Mer-AF1032A is represented by the following formula (I), along with its isomer antibiotic Mer-AF1032B. These patents disclose a method for preparing the antibiotics, which involves the cultivation of a strain belonging to the genus Penicillium. Additionally, a pharmaceutical composition comprising one of these antibiotics is useful as an antifungal agent.

Career Highlights

Hiroshi Nishida is associated with Mercian Corporation, where he has been instrumental in advancing antibiotic research. His innovative approaches have led to the development of new pharmaceutical solutions that address critical health challenges.

Collaborations

Nishida has worked alongside notable colleagues, including Takeo Yoshioka and Rokuro Okamoto. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Hiroshi Nishida's contributions to antibiotic development exemplify the importance of innovation in the pharmaceutical industry. His work continues to pave the way for new treatments that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…